| Session | Time | Topic | Faculty |
|---|---|---|---|
| 12:00 – 13:00 | Quiz Prelims: All Teams | Quiz Masters: Dr. Deepak Charles, Dr. Ashwin, Dr. Yashas | |
| Session 1 | PRECURSOR DISEASE & SMOLDERING MYELOMA | Chairpersons: Dr. Jose Easow, Dr. Bijay | |
| 13:35 – 13:50 | “When you cannot find a clone- how can the hematopathologist help?” | Dr. Anil Handoo | |
| 13:55 – 14:00 | Indian Data – MGUS | Dr. Uday Yanamandra | |
| 14:05 – 14:20 | Who, When, and How to Treat precursor conditions (including Smoldering Myeloma): Lessons for India from Global Trials | Dr. Vincent Rajkumar | |
| 14:25 – 14:40 | Debate: Should We Treat High-Risk Smoldering Myeloma in India Today? For: To treat Against: Not to treat |
For: To treat – Dr. Rahul Naithani Against: Not to treat – Dr. Chepsy Philip |
|
| 15:10 – 15:55 | Panel: Functional Imaging, Biomarkers, and AI Tools in Early Detection of Myeloma | Moderator: Dr. Joseph John Panelists: Dr. Ritu Gupta, Dr. Prashant Tembhare, Dr. Ankur Ahuja, Dr. Bhausaheb, Dr. Parathan, Dr. Rahul Ravind |
|
| 16:00 – 16:15 | “Existing role of SPE and sFLC in the diagnosis, monitoring, and prognosis of MM, and the future adoption of innovative technologies in achieving MRD.” | Dr. Anuj Prakash (KHC Healthcare Sponsored session) | |
| 16:00 – 16:30 | RUNNING TEA BREAK & INTERACTION | ||
| 16:30 – 18:00 | Inaugural Session with Secretary's report & Presidential Address & Vision 2030 Felicitation of the AIMS Director and Executive staff Felicitation of AMN colleagues Felicitation of IMS colleagues Felicitation of International Colleagues Felicitation of Supporters to IMAGe |
Gen. Velu Nair, Dr. Nikhil Munshi, Dr. Vincent Rajkumar, Mr. Daniel Navid, Dr. We Joo Chng, Dr. Shaji Kumar, Dr. Ravi Vij, Dr. Meera Mohan, Dr. Prashant Kapoor, Dr. Urvi Shah, Dr. Chandramouli, Dr. Parth Shah | |
| Session 2 | NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | Chairpersons: Dr. Reena Nair, Dr. Javed Rasool | |
| 18:00 – 18:15 | NDMM in India – Access, Choices, and Real-World Constraint – Indian Data | Brig (Dr) Sanjeevan Sharma | |
| 18:20 – 18:35 | Frontline Therapy in 2026: Triplets, Quadruplets, and the Role of ASCT | Dr. Chandramouli | |
| 18:40 – 18:55 | MRD as a Therapeutic Target and Surrogate of Cure: Can we adopt in clinical practice today? | Dr. Wee Joo Chng | |
| 19:00 – 19:45 | Panel: Transplant vs Non-Transplant in the Era of Quadruplets (Induction Choice, Role of ASCT, MRD-Driven Therapy) |
Moderator: Dr. Naveen Khattry Panelists: Dr. Nikhil C. Munshi, Dr. Reetu Jain, Dr. Sharath Damodar, Dr. Sandip Shah, Dr. Sumeet Mirgh, Dr. Jeevan, Dr. Suvir Singh |
|
| End of Day 1 : Dinner & Interaction | |||
| Session | Time | Topic | Faculty | |
|---|---|---|---|---|
| 7:30 – 09:00 AM | Mentor–Mentee Breakfast Interaction – Interactive Session | Breakout Sessions | ||
| Session 3: | High-Risk Myeloma | Chairpersons: Dr Deepak Mishra; Dr Tathagata Chatterjee | ||
| 09:00 – 09:15 AM | Risk stratification of MM in Indian context – challenges and pitfalls | Dr Sreejesh, PGI | ||
| 09:20 – 09:35 AM | “Functional or Genetic: What Truly Defines High-Risk Myeloma?” & Shifting Definitions of High-Risk and Risk-Adapted Treatment in Myeloma | Dr Nikhil Munshi | ||
| 09:40 – 09:55 AM | Integrating Cytogenetics, NGS, and MRD into High Risk Stratification – Where are we in 2026? | Dr Parth Shah | ||
| 10:00 – 10:45 AM | Panel: Frontline Immunotherapy and Transplant – Can We Overcome High-Risk Myeloma? | Moderator Dr Biju George Panelists: Dr Sanjeev; Dr Thomas Kuncheria, Dr Sachin Jadhav, Dr Gaurav Dixit, Dr Jose Easow | ||
| 10:45 – 11:15 AM | RUNNING TEA BREAK | |||
| Parallel Session | 11:30 – 12:30 AM |
E-Posters (Mini-Orals) – 6 Breakout sessions – 5 papers/room
The best five papers from this shall be presented the next day in the Oral paper session |
Dr. Ajay Sharma, Dr Ajay Gogia, Dr Reena Nair, Brig (Dr) Das, Dr Pankaj Malhotra;
Dr Shaji K Kumar, Dr Wee Joo Chng, Dr Chandramouli, Dr Meera Mohan, Dr Urvi Shah,De Tathagata Chatterjee,
Dr Hitha; Dr Roy Palatty; Dr Lekshmon K S; Dr Gohul G J; Dr Shinto; Dr Mathew Jose; Dr Thomas Kuncheria; Dr Nikhil M Kumar; Dr Rakesh; Dr Sudeep, Dr Chitresh, Dr Shreya, Dr Rashmi, Dr Akash. |
|
| Session 4: | Relapsed Myeloma – Non-Immunotherapy | Chairpersons: Dr Sandip Shah; Dr Dinesh Bhurani | ||
| 11:15 – 11:30 AM | Management of Relapsed Refractory Myeloma in Resource-Constrained Settings | Dr Lalit Kumar | ||
| 11:35 – 11:50 AM | Smart Sequencing in Relapsed Myeloma: Beyond Antibodies and CAR– Role of Alkylators, PIs, and Novel Oral Agents | Dr Ravi Vij | ||
| 11:55 – 12:40 PM | Panel: Balancing Efficacy, Toxicity, and Access in Relapsed Myeloma | Moderator: Dr Prantar Chakraborthy Panelists: Dr Ashish Dixit; Dr Chandran; Dr Hamza Dalal, Dr Tuphan, Dr Raghuveer Prabhu, Dr.Shinto | ||
| 12:45 – 13:30 PM | Lunch | |||
| Session 5: | Supportive Care, Systems & Multidisciplinary Care | Chairpersons: Dr Hari Menon; Dr Narayanakutty Warrier | ||
| 13:40 – 14:00 PM | Challenges of Infections in Myeloma | Dr Priya Sampathkumar | ||
| 14:05 – 14:25 PM | Importance of Nutrition in Myeloma | Dr Urvi Shah | ||
| 14:30 – 14:55 PM | Frailty as an important criterion for Myeloma Therapy | Dr Chandramouli | ||
| 15:00 – 15:55 PM | Panel Case Discussions: Renal, Neurological, Orthopaedic, Radiation Issues | Moderator: Dr Sadhashivadu Gundeti Panelists: Dr Arun Warrier, Dr Wesley Jose, Dr.Sudeep, Dr.Jim, Dr.Haridas, Dr.Gopikrishnan |
||
| 16:00 – 16:30 PM | RUNNING TEA BREAK | |||
| Session 6: | Amyloidosis & Dysproteinemias | Chairpersons: Col (Dr) Deepak Mishra; Brig (Dr) S Das | ||
| 16:30 – 16:45 PM | Cardiac Amyloidosis & India Astra Zeneca Sponsored Session |
Dr Hisham | ||
| 16:50 – 17:05 PM | AL Amyloidosis in 2025 – Early Diagnosis & Frontline Therapy | Dr Shaji Kumar | ||
| 17:10 – 17:25 PM | Indian Data – POEMS | Dr Aditya Jandial | ||
| 17:30 – 17:45 PM | Waldenström’s Macroglobulinemia – An Overview for Clinicians | Dr Prashant Kapoor | ||
| 17:50 – 18:05 PM | Indian Data – WM | Dr Charanpreet | ||
| 18:10 – 18:55 PM | Panel: Challenges in Diagnosis and Management of Other Dysproteinemias | Moderator: Dr. Hari Menon Panelists: Dr Dinesh Bhurani, Dr Sujith Karumathil, Dr Revanth, Dr.Sreeraj, Dr.Nikhil M Kumar, Dr.Kasi Vishwanathan | ||
| 19:00 – 20:00 PM | Cultural Event | |||
| End of Day 2 : Dinner Symposia – Teclistamab | ||||
| Session | Time | Topic | Faculty |
|---|---|---|---|
| 07:30 – 08:30 | Interactive Quiz with Trainees | Quiz Masters: Dr. Deepak Charles, Dr Ashwin; Dr Nitin Yashas | |
| 08:30 – 09:30 | Final Oral Paper Session | Judges: Lt Gen (Dr) Velu Nair, Dr Nikhil Munshi; Dr Prashant Kapoor; Dr Uday; Dr Neeraj Siddharthan | |
| Session 7: | RELAPSED MYELOMA – IMMUNOTHERAPY & SEQUENCING Chairpersons: Brig Dr Ajay Sharma; Dr Ajay Gogia |
||
| 09:35 – 09:50 | Valedictory ceremony / Prize Distribution | ||
| 09:55 – 10:10 | sBCMA as a Reliable Marker – Challenges and Opportunities | Dr. Neeraj Siddharthan | |
| 10:15 – 10:30 | CAR-T Therapy | Dr. Wee Joo Chng | |
| 10:35 – 10:50 | Bispecific in Myeloma Pfizer sponsored session |
Dr. Nikhil Munshi | |
| 10:55 – 11:10 | Results of SEHAT Study – Teclistamab in India | SEHAT Team | |
| 11:15 – 11:30 | Infections, CRS/ICANS, and other challenges in Immunotherapy | Dr. Meera Mohan | |
| 11:35 – 12:15 | Panel: CAR-T and BiTE Therapies: Opportunities & Challenges in India | Moderator: Dr. Sameer Melnkeri Panelists: Dr. Ajay Gogia; Dr. Shilpa Prabhu; Dr. Kishore; Dr. Esha Kaul; Dr. Varun Rajan; Brig Dr. Ajay Sharma |
|
| Parallel Session | 10:00 – 11:30 | Parallel Session – Patient Group meeting | Dr. Manoj, Dr. Sourabh, Dr. Sanju Cyriac, Dr. Abdul Majeed, Dr. Boban Thomas, Dr. Unni S Pillai, Dr. Unnikrishnan, Dr. Shaji K Kumar |
| 12:20 – 13:00 | Panel discussion: Treatment Access in India & South Asia. What is the future of Myeloma in India | Moderator: Dr. Pankaj Malhotra Panelists: Dr. Daniel Navid; Dr. Wee Joo Chng, Dr. Meera Mohan |
|
| 12:35 – 12:50 | Myeloma Cure: Are we able to see the end of the tunnel | Dr. Shaji Kumar | |
| 13:30 – 14:00 | Closing Remarks & Valedictory | Organizing Committee |